Several studies have since demonstrated that IGF-1 promotes cell motility and invasion in human breast carcinoma cell lines and mouse mammary tumor cells that signal preferentially through IRS-2, but not in cell lines that express only IRS-1 [70,84-86]. The gene discussed is IRS1; the disease is breast cancer.